More than 6 million people in the U.S. re living with Alzheimer’s, a disease that kills more people than breast cancer and prostate cancer combined.
Alzheimer's is a progressive disease and the most common type of dementia. It often starts with minor memory loss and can lead to the loss of the ability to control thoughts and language.
More than one in nine Americans ages 65 and older has Alzheimer’s — the sixth-leading cause of death in our country. And now, during the COVID-19 pandemic , Alzheimer's and dementia deaths have increased by 16%.
The Alzheimer’s Association projects that by 2050, Alzheimer’s will cost the U.S. more than $1.1 trillion.
Medicare Part B offers important coverage to combat this costly and incurable disease, including annual wellness visits, where your provider looks for signs of dementia, and a more thorough cognitive assessment to establish or confirm a diagnosis.
Providers or Medicare beneficiaries may wish to schedule an additional cognitive function review outside of the regular annual wellness visit. Here are a few questions you may have about the Alzheimer’s cognitive assessment.
Facts About the Alzheimer’s Cognitive Assessment
Medicare does cover Alzheimer's care, so call your doctor today to schedule a cognitive assessment.
LEGAL DISCLAIMER: The above is meant to be strictly educational and not intended to provide medical advice or solicit the sales of an insurance product or service of any kind.